Loading clinical trials...

Safety and Efficacy of Prolonged Use of Bivalirudin 4 Hours After ePCI (COBER Study) | Clinical Trials | Clareo Health

COMPLETEDNANCT04120961

Safety and Efficacy of Prolonged Use of Bivalirudin 4 Hours After ePCI (COBER Study)

Since the development of percutaneous coronary intervention (PCI) in patients with coronary heart disease (CHD), unfractionated heparin (UFH) and low molecular weight heparin (LWMH) have been the pref...

Lead sponsor: Nanjing First Hospital, Nanjing Medical University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

CTCA Prior to Invasive Angiography in Post-Bypass Patients (BYPASS CTCA 2)

NCT07165678 · Coronary Heart Disease

RECRUITINGPhase 1/2

A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease

NCT07493603 · Coronary Heart Disease, Coronary Artery Disease, and more

RECRUITING

Glycocalyx and Oxidative Stress in Endothelial Function (Part 2)

NCT07451873 · Coronary Heart Disease

RECRUITING

Clinical Outcomes of Patients With Coronary Artery Disease

NCT06216847 · Coronary Heart Disease (CHD)

RECRUITING

Village-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQUET Cohort Study

NCT07149688 · Atrial Fibrillation (AF), Hypertension, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 9, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment330

Start dateSep 2019

Last updatedAug 9, 2022

Condition

Coronary Heart Disease

Locations shown

Nanjing First Hospital, Nanjing Medical University

Nanjing, Jiangsu

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 9, 2022Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Safety and Efficacy of Prolonged Use of Bivalirudin 4 Hours After ePCI (COBER Study)

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

CTCA Prior to Invasive Angiography in Post-Bypass Patients (BYPASS CTCA 2)

A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease

Glycocalyx and Oxidative Stress in Endothelial Function (Part 2)

Clinical Outcomes of Patients With Coronary Artery Disease

Village-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQUET Cohort Study

Trial snapshot

Condition

Locations shown

For caregivers